Protein Intake and Resistance Training in Aging

February 12, 2019 updated by: Bruno Gualano, University of Sao Paulo

Different Protein and Derivatives Supplementation Strategies Combined With Resistance Training in Pre-frail and Frail Elderly

Resistance training combined with protein or amino acids supplementation has been shown to be promising for mitigating age-related disabilities and comorbidities. Randomized controlled trials supporting this possibility are still scarce. These series of clinical trials aim to investigate the chronic effects of different strategies of protein and derivatives supplementation in association with resistance training on selected health-related parameters in pre-frail and frail elderly.This is a 16-month, double-blind, randomized, placebo-controlled, parallel-group clinical trial involving a series of investigations. Participants will be divided into nine groups, allowing the assessement of the effects of (1) isolated leucine supplementation; (2) protein source (whey vs. soy); (3) combination of whey protein and creatine; and (4) sexual dimorphism to the response of protein intake plus resistance training (men vs. women). All participants will undergo a supervised, resistance training program.

Study Overview

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sao Paulo, Brazil, 05508030
        • University of Sao Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • elderly people
  • frailty or pre-frailty, according to Fried et al., (2001) criteria.

Exclusion Criteria:

  • on exogenous insulin and steroid-based drugs
  • chronic obstructive pulmonary disease or respiratory failure
  • use of protein and /or amine-based dietary supplements
  • on restrictive diets (e.g. calorie or food group restrictions)
  • on resistance training
  • untreated cardiovascular, metabolic, or other chronic disease
  • any musculoskeletal condition precluding resistance training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
alanine as placebo to leucine (same dosage); corn starch as placebo to protein and/or creatine (same dosage)
Experimental: whey protein
30 g in total; twice a day (morning and evening)
Experimental: soy protein
30 g in total; twice a day
Experimental: leucine supplementation
7.5 g/d in total; three times per day
Experimental: whey plus creatine
whey protein combined with creatine (30 g and 6.0 g in total; twice a day, respectively)
Experimental: creatine
6.0 g in total; twice a day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lean mass
Time Frame: 4 months
assessed by Dual-energy X-ray absorptiometry
4 months
muscle function
Time Frame: 4 months
assessed by a battery of physical tests
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bone mass
Time Frame: 4 months
assessed by Dual-energy X-ray absorptiometry
4 months
insulin sensitivity
Time Frame: 4 months
assessed by homeostasis model assessment (HOMA index)
4 months
health related-quality of life
Time Frame: 4 months
assessed by Short-Form Health Survey (SF-36) (score range: 0 to 100, higher values mean better quality of life)
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

August 30, 2017

Study Completion (Actual)

August 30, 2017

Study Registration Dates

First Submitted

June 26, 2013

First Submitted That Met QC Criteria

June 26, 2013

First Posted (Estimate)

July 1, 2013

Study Record Updates

Last Update Posted (Actual)

February 15, 2019

Last Update Submitted That Met QC Criteria

February 12, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • The Pro Elderly Study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Clinical Trials on placebo

3
Subscribe